2020 Expert Consensus Decision Pathway on Novel Therapies for CV Risk Reduction in Diabetes Patients - Public Comment Survey

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes


Public Comment Period
February 12 - 26, 2020



The ACC is seeking comments on a preliminary draft of the 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes.

The purpose of this document is to update the 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease (ASCVD), incorporating the abundance of new outcomes data since the previous publication, which includes the expanded use of SGLT2is in patient populations outside of those who have established ASCVD.

This draft will be edited based on comments received during the public comment period. The final draft will be submitted to the leadership of the ACC for approval and will be published in the Journal of the American College of Cardiology.

Please enter the information below and then click the "Submit" button.  A new page will appear which will contain links to the Public Comment Draft and Public Comment Response Form.  Please click on the links to access the documents.

Please email your completed Public Comment Response Form to pathwaycomment@acc.org. 

Questions?  Please contact pathwaycomment@acc.org.

Thank you for participating in this public comment process.

Current Practice Setting (select all that apply): 
Years in Practice:
Type of Practitioner:
Areas of Specialty (select all that apply):
100% Complete